132 related articles for article (PubMed ID: 12080957)
1. Fabrazyme--recombinant protein treatment for Fabry's disease.
Barngrover D
J Biotechnol; 2002 May; 95(3):280-2. PubMed ID: 12080957
[No Abstract] [Full Text] [Related]
2. Enzyme replacement in the treatment of Fabry's disease. Is there a point-of-no-return?
del Toro N; Milán JA; Palma A
Nephrol Dial Transplant; 2004 Apr; 19(4):1018. PubMed ID: 15031378
[No Abstract] [Full Text] [Related]
3. First treatment for Fabry's disease.
FDA Consum; 2003; 37(4):4. PubMed ID: 12971327
[No Abstract] [Full Text] [Related]
4. Enzyme therapy for Fabry's disease: registered for success?
Knebelmann B; Kurschat C; Thadhani R
Lancet; 2009 Dec; 374(9706):1950-1. PubMed ID: 19959220
[No Abstract] [Full Text] [Related]
5. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
Mignani R; Cagnoli L
J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy for Fabry's disease.
Waldek S; Germain DP; Wanner C; Warnock DG
Lancet; 2010 May; 375(9725):1523; author reply 1523-4. PubMed ID: 20435225
[No Abstract] [Full Text] [Related]
7. Enzyme replacement therapy for Fabry's disease.
Deegan P
Lancet; 2010 May; 375(9725):1522-3; author reply 1523-4. PubMed ID: 20435224
[No Abstract] [Full Text] [Related]
8. Shire drops 'emergency' Fabry's disease drug.
Fox JL
Nat Biotechnol; 2012 Jun; 30(6):478. PubMed ID: 22678371
[No Abstract] [Full Text] [Related]
9. Agalsidase beta (Fabrazyme) for Fabry disease.
Med Lett Drugs Ther; 2003 Sep; 45(1165):74-5. PubMed ID: 12968124
[No Abstract] [Full Text] [Related]
10. [Efficacy of replacement enzyme therapy on central nervous system manifestations in Fabry's disease].
Besson G; Vadot W; Guellerin J
Rev Med Interne; 2010 Dec; 31 Suppl 2():S257-9. PubMed ID: 21211675
[TBL] [Abstract][Full Text] [Related]
11. PR interval and the response to enzyme-replacement therapy for Fabry's disease.
Waldek S
N Engl J Med; 2003 Mar; 348(12):1186-7. PubMed ID: 12646684
[No Abstract] [Full Text] [Related]
12. [Fabry's disease. An orphan disease that has found a solution: enzymatic replacement with alpha-galactosidase].
Selgas R; García de Lorenzo A; Valdés F; Beck M
Nefrologia; 2001; 21(5):443-7. PubMed ID: 11795012
[No Abstract] [Full Text] [Related]
13. Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function.
De Schoenmakere G; Chauveau D; Grünfeld JP
Nephrol Dial Transplant; 2003 Jan; 18(1):33-5. PubMed ID: 12480957
[TBL] [Abstract][Full Text] [Related]
14. [Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients].
Cianciaruso B; Pisani A; Andreucci MV; Parente N; Andria G; Federico S; Sabbatini M; Sessa A
G Ital Nefrol; 2003; 20(2):113-9. PubMed ID: 12746795
[TBL] [Abstract][Full Text] [Related]
15. Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy.
Prinz C; Farr M; Hering D; Horstkotte D; Faber L
Clin Res Cardiol; 2010 Jan; 99(1):53-5. PubMed ID: 19774328
[No Abstract] [Full Text] [Related]
16. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.
Spinelli L; Pisani A; Sabbatini M; Petretta M; Andreucci MV; Procaccini D; Lo Surdo N; Federico S; Cianciaruso B
Clin Genet; 2004 Aug; 66(2):158-65. PubMed ID: 15253767
[TBL] [Abstract][Full Text] [Related]
17. Does enzyme replacement therapy improve symptoms of Fabry disease in patients undergoing dialysis?
Banikazemi M; Desnick RJ
Nat Clin Pract Nephrol; 2006 Feb; 2(2):72-3. PubMed ID: 16932395
[No Abstract] [Full Text] [Related]
18. New therapies for Fabry's disease.
Gahl WA
N Engl J Med; 2001 Jul; 345(1):55-7. PubMed ID: 11439950
[No Abstract] [Full Text] [Related]
19. Renal histology before and after effective enzyme replacement therapy in a patient with classical Fabry's disease.
Hirashio S; Taguchi T; Naito T; Maki K; Ogata S; Taniyama K; Taniguchi Y; Yorioka N
Clin Nephrol; 2009 May; 71(5):550-6. PubMed ID: 19473616
[TBL] [Abstract][Full Text] [Related]
20. Immune response to enzyme replacement therapy in Fabry disease: impact on clinical outcome?
Hollak CE; Linthorst GE
Mol Genet Metab; 2009 Jan; 96(1):1-3. PubMed ID: 19062323
[No Abstract] [Full Text] [Related]
[Next] [New Search]